Using scans to find early pancreas cancer in newly diagnosed diabetes patients
Part of Cancer, Hormones & metabolism clinical trials.
This study will see if people over 50 with new-onset diabetes can benefit from imaging scans (CT or endoscopic ultrasound) to help catch pancreatic ductal adenocarcinoma at an early stage. The goal is to screen those who might be at higher risk based on the END-PDAC score.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 50 years.
- You must have been recently diagnosed with diabetes based on blood sugar tests (fasting blood sugar, post-meal blood sugar, or HbA1C).
- You must have a blood sugar test from 6 to 18 months ago that was normal (not higher than 125 mg/dL).
- Your END-PDAC score must be more than 2 (this is a risk score your doctor calculates).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
This study screens people with recent diabetes who are at high risk for pancreatic cancer. It uses a CT scan to find cancer early, when it may be easier to treat.
This study checks people who are at higher risk for pancreatic cancer using an ultrasound camera passed into the digestive tract (endoscopic ultrasound, EUS), then tracks their results over time. It may help catch early signs and better understand how screening works for high-risk groups.
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.